CBCV
Cannabichromevarin

How it occurs

A naturally occurring propyl analog related to CBC and usually detected only in small amounts.

Relationship to other cannabinoids

Part of the wider cannabinoid family; its exact pathway and relevance depend on the compound and source material.

What is established

Its chemical identity and natural occurrence have been reported.

Commonly reported effects

Reliable consumer-effect patterns are not established. Product marketing and isolated anecdotes should not be treated as clinical evidence.

Anecdotal or marketing-led unless stated otherwise

What remains uncertain

Consumer effects and therapeutic uses have not been established in robust human trials.

Evidence quality

Mostly analytical and preclinical evidence.

Safety and potential interactions

Reliable dose, interaction, and long-term safety evidence is absent.

Vaporization relevance

Heating can change cannabinoid form and delivery, but laboratory boiling points do not define a universal device setting. Heater design, sensor position, airflow, material, load, and draw behavior all affect exposure. This entry makes no compound-specific temperature recommendation.

Legal and regulatory context

Product source, composition, claims, and jurisdiction determine treatment.

Dated source foundation

Direct authoritative sources reviewed 2026-08-20. These sources support the safety and regulatory boundaries of this draft; a scientific editor must still verify compound-specific claims against current peer-reviewed literature.

• FDA — Cannabis and cannabis-derived products: questions and answers ↗
• FDA — What to know about cannabis and CBD products ↗
• NIDA — Cannabis (Marijuana) ↗
• CDC — Cannabis frequently asked questions ↗

Related entries

THC · CBD · CBG

← All encyclopedia entries